IDEXX Laboratories, Inc. (IDXX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for IDEXX Laboratories, Inc. (IDXX:NASDAQ), powered by AI.

Current Price
$573.00
P/E Ratio
43.5
Market Cap
46.1B
Sector
Healthcare
What is the IDEXX Laboratories, Inc. stock price forecast?

IDEXX Laboratories, Inc. is currently trading at $573.00. View real-time AI analysis on Alpha Lenz.

What is IDEXX Laboratories, Inc. insider trading activity?

View the latest insider trading data for IDEXX Laboratories, Inc. on Alpha Lenz.

What is IDEXX Laboratories, Inc.'s P/E ratio?

IDEXX Laboratories, Inc.'s P/E ratio is 43.5.

IDEXX Laboratories, Inc.

NASDAQ · IDXX
$573.00+3.00(+0.53%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about IDEXX Laboratories, Inc.'s future dividend policy...
Alpha Chat Insight

IDEXX Laboratories, Inc. trades at a P/E of 43.5 (premium valuation) with strong ROE of 66.2%. Operating margin of 31.6% indicates strong profitability.

Ask for details

Company Overview

IDEXX Laboratories, Inc. is a global leader in the medical devices sector, specializing in the development, manufacture, and distribution of diagnostic products and services for animal health, water testing, and food safety. The company’s primary focus is on veterinary diagnostics, supplying point-of-care testing systems, advanced laboratory instruments, rapid assay test kits, and software that support companion animal veterinary practices. Its key products also address microbiological water quality monitoring and the detection of diseases in livestock and poultry, enabling critical biosecurity and animal health management. IDEXX Laboratories has established a significant presence in over 175 countries, leveraging both direct distribution and a network of resellers to reach veterinary clinics, farms, laboratories, and public health entities globally. Headquartered in Westbrook, Maine, and employing around 11,000 people, IDEXX is recognized for its commitment to innovation, robust research and development initiatives, and an expansive product suite that positions it as a cornerstone of animal health and environmental diagnostics worldwide.

CEOMr. Jonathan J. Mazelsky
SectorHealthcare
IndustryDiagnostics & Research
Employees11,000

Company Statistics

FY 2025

Profile

$46.08BMarket Cap
$4.30BRevenue
0.00Shares Out
11,000Employees

Margins

61.80%Gross
35.04%EBITDA
31.60%Operating
30.77%Pre-Tax
24.62%Net

Valuation

43.50P/E
28.71P/B
10.71EV/Sales
31.08EV/EBITDA
44.16P/FCF

Growth (CAGR)

8.52%Rev 3Yr
9.72%Rev 5Yr
14.81%Op Inc 3Yr
14.39%Op Inc 5Yr
15.98%Net Inc 3Yr
12.72%Net Inc 5Yr

Returns

31.89%ROA
66.20%ROE
41.03%ROIC

Financial Health

$180.07MCash & Cash Equivalents
$1.57BNet Debt
108.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

IDEXX Laboratories, Inc. (ticker: IDXX) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 11,000 employees. Market cap is $46.1B.

The current price is $573 with a P/E ratio of 43.5x and P/B of 28.71x.

ROE is 66.20% and operating margin is 31.60%. Annual revenue is $4.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
IDEXX Laboratories, Inc. (IDXX) Stock Forecast 2026 $573.00 — Price, Financials & Analyst Targets | Alpha Lenz